{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T05:15:48Z","timestamp":1778044548168,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503988"],"award-info":[{"award-number":["82503988"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002799"],"award-info":[{"award-number":["82002799"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473499"],"award-info":[{"award-number":["82473499"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403922"],"award-info":[{"award-number":["82403922"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473273"],"award-info":[{"award-number":["82473273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["SQ2023YFF0600039"],"award-info":[{"award-number":["SQ2023YFF0600039"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3402504"],"award-info":[{"award-number":["2023YFC3402504"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["22Y11912800"],"award-info":[{"award-number":["22Y11912800"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["20ZR1412400"],"award-info":[{"award-number":["20ZR1412400"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-04655-9","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:05:35Z","timestamp":1774591535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Age-related genomic characterization and therapeutic targets in Chinese breast cancer: insights from prospective targeted sequencing and clinical data analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Xin-Yi","family":"Sui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Qing","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Ming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"issue":"9472","key":"4655_CR1","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/S0140-6736(05)66546-4","volume":"365","author":"U Veronesi","year":"2005","unstructured":"Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G. Breast cancer. Lancet (London, England). 2005;365(9472):1727\u201341.","journal-title":"Lancet (London, England)"},{"issue":"7","key":"4655_CR2","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/S1470-2045(13)70567-9","volume":"15","author":"L Fan","year":"2014","unstructured":"Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, et al. Breast cancer in China. Lancet Oncol. 2014;15(7):e279-289.","journal-title":"Lancet Oncol"},{"issue":"3","key":"4655_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s13304-017-0424-1","volume":"69","author":"Z Anastasiadi","year":"2017","unstructured":"Anastasiadi Z, Lianos GD, Ignatiadou E, Harissis HV, Mitsis M. Breast cancer in young women: an overview. Update Surg. 2017;69(3):313\u20137.","journal-title":"Update Surg"},{"issue":"4","key":"4655_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-014-0427-5","volume":"16","author":"HA Azim Jr.","year":"2014","unstructured":"Azim HA Jr., Partridge AH. Biology of breast cancer in young women. Breast Cancer Res. 2014;16(4):427.","journal-title":"Breast Cancer Res"},{"issue":"4","key":"4655_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4048\/jbc.2014.17.4.301","volume":"17","author":"HB Lee","year":"2014","unstructured":"Lee HB, Han W. Unique features of young age breast cancer and its management. J Breast Cancer. 2014;17(4):301\u20137.","journal-title":"J Breast Cancer"},{"issue":"20","key":"4655_CR6","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1200\/JCO.2007.14.2471","volume":"26","author":"CK Anders","year":"2008","unstructured":"Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008;26(20):3324\u201330.","journal-title":"J Clin Oncol"},{"issue":"3","key":"4655_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1053\/j.seminoncol.2009.03.001","volume":"36","author":"CK Anders","year":"2009","unstructured":"Anders CK, Johnson R, Litton J, Phillips M, Bleyer A. Breast cancer before age 40 years. Semin Oncol. 2009;36(3):237\u201349.","journal-title":"Semin Oncol"},{"issue":"11","key":"4655_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007695","volume":"4","author":"H Fredholm","year":"2009","unstructured":"Fredholm H, Eaker S, Frisell J, Holmberg L, Fredriksson I, Lindman H. Breast cancer in young women: poor survival despite intensive treatment. PLoS One. 2009;4(11):e7695.","journal-title":"PLoS One"},{"issue":"11","key":"4655_CR9","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/s41588-021-00949-1","volume":"53","author":"P Srinivasan","year":"2021","unstructured":"Srinivasan P, Bandlamudi C, Jonsson P, Kemel Y, Chavan SS, Richards AL, et al. The context-specific role of germline pathogenicity in tumorigenesis. Nat Genet. 2021;53(11):1577\u201385.","journal-title":"Nat Genet"},{"key":"4655_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18020308","author":"R Kamps","year":"2017","unstructured":"Kamps R, Brand\u00e3o RD, Bosch BJ, Paulussen AD, Xanthoulea S, Blok MJ, et al. Next-generation sequencing in oncology: genetic diagnosis, risk prediction and cancer classification. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18020308.","journal-title":"Int J Mol Sci"},{"issue":"13","key":"4655_CR11","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","volume":"34","author":"N Tung","year":"2016","unstructured":"Tung N, Lin NU, Kidd J, Allen BA, Singh N, Wenstrup RJ, et al. Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer. J Clin Oncol. 2016;34(13):1460\u20138.","journal-title":"J Clin Oncol"},{"issue":"5","key":"4655_CR12","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72(5):1117\u201330.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"4655_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04129-4","volume":"9","author":"Z Kan","year":"2018","unstructured":"Kan Z, Ding Y, Kim J, Jung HH, Chung W, Lal S, et al. Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures. Nat Commun. 2018;9(1):1725.","journal-title":"Nat Commun"},{"issue":"6","key":"4655_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylk\u00e4s K, Roberts J, et al. Breast-cancer risk in families with mutations in PALB2. N Engl J Med. 2014;371(6):497\u2013506.","journal-title":"N Engl J Med"},{"issue":"9","key":"4655_CR15","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","volume":"3","author":"FJ Couch","year":"2017","unstructured":"Couch FJ, Shimelis H, Hu C, Hart SN, Polley EC, Na J, et al. Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol. 2017;3(9):1190\u20136.","journal-title":"JAMA Oncol"},{"key":"4655_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.breast.2016.05.006","volume":"28","author":"Z Kleibl","year":"2016","unstructured":"Kleibl Z, Kristensen VN. Women at high risk of breast cancer: molecular characteristics, clinical presentation and management. Breast. 2016;28:136\u201344.","journal-title":"Breast"},{"issue":"1","key":"4655_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-6684-z","volume":"20","author":"NE Mealey","year":"2020","unstructured":"Mealey NE, O\u2019Sullivan DE, Pader J, Ruan Y, Wang E, Quan ML, et al. Mutational landscape differences between young-onset and older-onset breast cancer patients. BMC Cancer. 2020;20(1):212.","journal-title":"BMC Cancer"},{"issue":"11","key":"4655_CR18","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1158\/1078-0432.CCR-21-2572","volume":"28","author":"AG Waks","year":"2022","unstructured":"Waks AG, Kim D, Jain E, Snow C, Kirkner GJ, Rosenberg SM, et al. Somatic and germline genomic alterations in very young women with breast cancer. Clin Cancer Res. 2022;28(11):2339\u201348.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"4655_CR19","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1111\/cas.13982","volume":"110","author":"C Park","year":"2019","unstructured":"Park C, Yoon KA, Kim J, Park IH, Park SJ, Kim MK, et al. Integrative molecular profiling identifies a novel cluster of estrogen receptor-positive breast cancer in very young women. Cancer Sci. 2019;110(5):1760\u201370.","journal-title":"Cancer Sci"},{"issue":"1","key":"4655_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19342-3","volume":"11","author":"GT Lang","year":"2020","unstructured":"Lang GT, Jiang YZ, Shi JX, Yang F, Li XG, Pei YC, et al. Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing. Nat Commun. 2020;11(1):5679.","journal-title":"Nat Commun"},{"issue":"16","key":"4655_CR21","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","volume":"28","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology\/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28(16):2784\u201395.","journal-title":"J Clin Oncol"},{"issue":"26","key":"4655_CR22","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1200\/JCO.2016.70.5319","volume":"35","author":"WM Hanna","year":"2017","unstructured":"Hanna WM, Slodkowska E, Lu FI, Nafisi H, Nofech-Mozes S. Comparative analysis of human epidermal growth factor receptor 2 testing in breast cancer according to 2007 and 2013 American Society of Clinical Oncology\/College of American Pathologists guideline recommendations. J Clin Oncol. 2017;35(26):3039\u201345.","journal-title":"J Clin Oncol"},{"issue":"2","key":"4655_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S1470-2045(23)00579-X","volume":"25","author":"L Fan","year":"2024","unstructured":"Fan L, Wang ZH, Ma LX, Wu SY, Wu J, Yu KD, et al. Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial. Lancet Oncol. 2024;25(2):184\u201397.","journal-title":"Lancet Oncol"},{"issue":"2","key":"4655_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ajhg.2017.01.004","volume":"100","author":"Q Li","year":"2017","unstructured":"Li Q, Wang K. InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines. Am J Hum Genet. 2017;100(2):267\u201380.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"4655_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cell.2018.03.039","volume":"173","author":"KL Huang","year":"2018","unstructured":"Huang KL, Mashl RJ, Wu Y, Ritter DI, Wang J, Oh C, et al. Pathogenic germline variants in 10,389 adult cancers. Cell. 2018;173(2):355-370.e314.","journal-title":"Cell"},{"issue":"7483","key":"4655_CR26","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nature12981","volume":"505","author":"N Rahman","year":"2014","unstructured":"Rahman N. Realizing the promise of cancer predisposition genes. Nature. 2014;505(7483):302\u20138.","journal-title":"Nature"},{"issue":"7","key":"4655_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"4655_CR28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"key":"4655_CR29","unstructured":"Chen C, Lin CJ, Pei YC, Ma D, Liao L, Li SY, Fan L, Di GH, Wu SY, Liu XY, et al. 4079 breast cancer target sequencing. 2022 Fudan Data Portal.\u00a02022.\u00a0https:\/\/data.3steps.cn\/cdataportal\/study\/summary?id=FUSCC_BRCA_panel_4000."},{"key":"4655_CR30","unstructured":"Samstein RM, Lee CH, Shoushtari AN, Hellmann MD, Shen R, Janjigian YY, Barron DA, Zehir A, Jordan EJ, Omuro A, et al. Genomic and survival data from 1661 tumor-normal pairs from 1661 patients with various cancer types sequenced with the MSK-IMPACT assay. 2018. cBioPortal http:\/\/www.cbioportal.org\/study\/summary?id=tmb_mskcc_2018."},{"key":"4655_CR31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1146\/annurev-cancerbio-030617-050502","volume":"2","author":"CC Chen","year":"2018","unstructured":"Chen CC, Feng W, Lim PX, Kass EM, Jasin M. Homology-directed repair and the role of BRCA1, BRCA2, and related proteins in genome integrity and cancer. Annu Rev Cancer Biol. 2018;2:313\u201336.","journal-title":"Annu Rev Cancer Biol"},{"issue":"1","key":"4655_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10549-019-05442-2","volume":"179","author":"EH Allott","year":"2020","unstructured":"Allott EH, Shan Y, Chen M, Sun X, Garcia-Recio S, Kirk EL, et al. Bimodal age distribution at diagnosis in breast cancer persists across molecular and genomic classifications. Breast Cancer Res Treat. 2020;179(1):185\u201395.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"4655_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.14740\/wjon1424","volume":"13","author":"S Desai","year":"2022","unstructured":"Desai S, Guddati AK. Bimodal age distribution in cancer incidence. World J Oncol. 2022;13(6):329\u201336.","journal-title":"World J Oncol"},{"issue":"1","key":"4655_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-023-00614-3","volume":"9","author":"C Chen","year":"2023","unstructured":"Chen C, Lin CJ, Pei YC, Ma D, Liao L, Li SY, et al. Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities. Cell Discov. 2023;9(1):125.","journal-title":"Cell Discov"},{"issue":"14","key":"4655_CR35","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1002\/cncr.32922","volume":"126","author":"D Ma","year":"2020","unstructured":"Ma D, Jiang YZ, Xiao Y, Xie MD, Zhao S, Jin X, et al. Integrated molecular profiling of young and elderly patients with triple-negative breast cancer indicates different biological bases and clinical management strategies. Cancer. 2020;126(14):3209\u201318.","journal-title":"Cancer"},{"issue":"1","key":"4655_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01284-9","volume":"22","author":"O Mart\u00ednez-S\u00e1ez","year":"2020","unstructured":"Mart\u00ednez-S\u00e1ez O, Chic N, Pascual T, Adamo B, Vidal M, Gonz\u00e1lez-Farr\u00e9 B, et al. Frequency and spectrum of PIK3CA somatic mutations in breast cancer. Breast Cancer Res. 2020;22(1):45.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"4655_CR37","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.annonc.2020.11.011","volume":"32","author":"F Andr\u00e9","year":"2021","unstructured":"Andr\u00e9 F, Ciruelos EM, Juric D, Loibl S, Campone M, Mayer IA, et al. Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1. Ann Oncol. 2021;32(2):208\u201317.","journal-title":"Ann Oncol"},{"issue":"6","key":"4655_CR38","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1056\/NEJMoa1109653","volume":"366","author":"J Baselga","year":"2012","unstructured":"Baselga J, Campone M, Piccart M, Burris HA 3rd, Rugo HS, Sahmoud T, et al. Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. N Engl J Med. 2012;366(6):520\u20139.","journal-title":"N Engl J Med"},{"issue":"12","key":"4655_CR39","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1093\/annonc\/mdu456","volume":"25","author":"M Piccart","year":"2014","unstructured":"Piccart M, Hortobagyi GN, Campone M, Pritchard KI, Lebrun F, Ito Y, et al. Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2\u2020. Ann Oncol. 2014;25(12):2357\u201362.","journal-title":"Ann Oncol"},{"issue":"4","key":"4655_CR40","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jtho.2018.12.013","volume":"14","author":"M Scheffler","year":"2019","unstructured":"Scheffler M, Ihle MA, Hein R, Merkelbach-Bruse S, Scheel AH, Siemanowski J, et al. K-ras mutation subtypes in NSCLC and associated co-occuring mutations in other oncogenic pathways. J Thorac Oncol. 2019;14(4):606\u201316.","journal-title":"J Thorac Oncol"},{"issue":"7","key":"4655_CR41","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1158\/1078-0432.CCR-21-3418","volume":"28","author":"CX Ma","year":"2022","unstructured":"Ma CX, Luo J, Freedman RA, Pluard TJ, Nangia JR, Lu J, et al. The phase II MutHER study of neratinib alone and in combination with fulvestrant in HER2-mutated, non-amplified metastatic breast cancer. Clin Cancer Res. 2022;28(7):1258\u201367.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"4655_CR42","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jtho.2020.02.003","volume":"15","author":"I Eguren-Santamaria","year":"2020","unstructured":"Eguren-Santamaria I, Sanmamed MF, Gil-Bazo I. Are immune checkpoint inhibitors effective against uncommon oncogene-driven NSCLC subtypes? J Thorac Oncol. 2020;15(4):489\u201392.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"4655_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06581-8","volume":"9","author":"Y Momozawa","year":"2018","unstructured":"Momozawa Y, Iwasaki Y, Parsons MT, Kamatani Y, Takahashi A, Tamura C, et al. Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls. Nat Commun. 2018;9(1):4083.","journal-title":"Nat Commun"},{"issue":"4","key":"4655_CR44","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.annonc.2023.01.009","volume":"34","author":"SJ Luen","year":"2023","unstructured":"Luen SJ, Viale G, Nik-Zainal S, Savas P, Kammler R, Dell\u2019Orto P, et al. Genomic characterisation of hormone receptor-positive breast cancer arising in very young women. Ann Oncol. 2023;34(4):397\u2013409.","journal-title":"Ann Oncol"},{"issue":"11","key":"4655_CR45","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1002\/ijc.32877","volume":"146","author":"H Meng","year":"2020","unstructured":"Meng H, Yao L, Yuan H, Xu Y, Ouyang T, Li J, et al. BRCA1 c.5470_5477del, a founder mutation in Chinese Han breast cancer patients. Int J Cancer. 2020;146(11):3044\u201352.","journal-title":"Int J Cancer"},{"issue":"1","key":"4655_CR46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.annonc.2020.10.471","volume":"32","author":"PA Fasching","year":"2021","unstructured":"Fasching PA, Link T, Hauke J, Seither F, Jackisch C, Klare P, et al. Neoadjuvant paclitaxel\/olaparib in comparison to paclitaxel\/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study). Ann Oncol. 2021;32(1):49\u201357.","journal-title":"Ann Oncol"},{"issue":"2","key":"4655_CR47","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.annonc.2020.11.009","volume":"32","author":"HP Eikesdal","year":"2021","unstructured":"Eikesdal HP, Yndestad S, Elzawahry A, Llop-Guevara A, Gilje B, Blix ES, et al. Olaparib monotherapy as primary treatment in unselected triple negative breast cancer. Ann Oncol. 2021;32(2):240\u20139.","journal-title":"Ann Oncol"},{"issue":"9","key":"4655_CR48","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1200\/JCO.22.01239","volume":"41","author":"S Yadav","year":"2023","unstructured":"Yadav S, Boddicker NJ, Na J, Polley EC, Hu C, Hart SN, et al. Contralateral breast cancer risk among carriers of germline pathogenic variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2. J Clin Oncol. 2023;41(9):1703\u201313.","journal-title":"J Clin Oncol"},{"issue":"7872","key":"4655_CR49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41586-021-03779-7","volume":"596","author":"KS Ruth","year":"2021","unstructured":"Ruth KS, Day FR, Hussain J, Mart\u00ednez-Marchal A, Aiken CE, Azad A, et al. Genetic insights into biological mechanisms governing human ovarian ageing. Nature. 2021;596(7872):393\u20137.","journal-title":"Nature"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04655-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04655-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04655-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T05:04:38Z","timestamp":1778043878000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04655-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4655"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04655-9","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"16 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted with approval from the institutional review board and adhered to Good Clinical Practice guidelines and the Declaration of Helsinki. Ethical approval was obtained from Fudan University Shanghai Cancer Center (Ethics Approval No. 2301268\u201317).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"293"}}